Scg. Hui et al., PREVENTION BY THE 5-HT3 RECEPTOR ANTAGONIST, ONDANSETRON, OF MORPHINE-DEPENDENCE AND TOLERANCE IN THE RAT, British Journal of Pharmacology, 118(4), 1996, pp. 1044-1050
1 The effect of ondansetron, a selective 5-hydroxytryptamine(3) (5-HT3
) receptor antagonist, was studied in morphine-addicted rats. Morphine
-dependence and tolerance, induced by drinking increasing concentratio
ns of morphine sulphate in 5% sucrose solution for 3 weeks, were demon
strated by the naloxone-precipitated withdrawal syndrome and tail flic
k response to a thermal noxious stimulus (water at 50 degrees C), resp
ectively. 2 Morphine-dependence, assessed by naloxone precipitated wit
hdrawal, was undetectable by the 6th day, when the animals drank only
tap water for 7 days after the 3-week induction period. 3 When detoxif
ied rats were offered sucrose and morphine solutions for 10 days, the
recurrence of opiate solution preference with relapse to dependence an
d tolerance was observed. 4 Giving ondansetron (0.1 or 1 mu g kg(-1);
i.p.; twice daily) on the 14th day of, or 7 days prior to, the 3-week
induction period reduced dependence and tolerance seen during the 3-we
ek morphine induction and the 10-day drinking preference periods. 5 5-
Hydroxytryptamine(2) (5-HT2) receptor antagonism by cyproheptadine (10
0 or 250 mu g kg(-1); i.p.; twice daily) did not influence morphine-de
pendence and tolerance. 6 These findings suggest that ondansetron may
be useful for treating opiate addiction and lowering the recidivism ra
te.